financetom
Business
financetom
/
Business
/
Cullen/Frost Bankers Insider Sold Shares Worth $1,603,675, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cullen/Frost Bankers Insider Sold Shares Worth $1,603,675, According to a Recent SEC Filing
Feb 3, 2025 10:29 AM

01:13 PM EST, 02/03/2025 (MT Newswires) -- Paul Bracher, President of CFR, on January 31, 2025, sold 11,500 shares in Cullen/Frost Bankers ( CFR ) for $1,603,675. Following the Form 4 filing with the SEC, Bracher has control over a total of 151,797 common shares of the company, with 102,946 shares held directly and 48,851 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/39263/000003926325000010/xslF345X05/wk-form4_1738605726.xml

Price: 136.70, Change: -2.71, Percent Change: -1.94

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TechnipFMC Q2 Adjusted Earnings, Revenue Increase
TechnipFMC Q2 Adjusted Earnings, Revenue Increase
Jul 25, 2024
07:40 AM EDT, 07/25/2024 (MT Newswires) -- TechnipFMC ( FTI ) reported Q2 adjusted earnings Thursday of $0.43 per diluted share, up from $0.10 a year earlier. Analysts polled by Capital IQ expected $0.31. Revenue for the quarter ended June 30 was $2.33 billion, up from $1.97 billion a year earlier. Analysts surveyed by Capital IQ expected $2.23 billion. TechnipFMC...
Masco's Q2 Adjusted Net Income Rises, Sales Fall; 2024 Adjusted EPS Outlook Revised
Masco's Q2 Adjusted Net Income Rises, Sales Fall; 2024 Adjusted EPS Outlook Revised
Jul 25, 2024
07:38 AM EDT, 07/25/2024 (MT Newswires) -- Masco ( MAS ) reported Q2 adjusted net income Thursday of $1.20 per share, up from $1.19 a year earlier. Analysts polled by Capital IQ expected $1.18. Net sales for the quarter ended June 30 were $2.09 billion, down from $2.13 billion a year earlier. Analysts surveyed by Capital IQ expected $2.10 billion....
AbbVie lifts annual profit forecast on strong immunology drug sales
AbbVie lifts annual profit forecast on strong immunology drug sales
Jul 25, 2024
(Reuters) - AbbVie ( ABBV ) raised its annual profit forecast on Thursday as strong sales of its key immunology drugs, including Humira, helped it beat Wall Street expectations for the second quarter. Sales of Humira, once the world's top-selling drug, have been declining since its close copies, or biosimilars, hit the U.S. market. There are now 10 Humira biosimilars...
Top Premarket Gainers
Top Premarket Gainers
Jul 25, 2024
07:34 AM EDT, 07/25/2024 (MT Newswires) -- BloomZ ( BLMZ ) shares surged 24% pre-bell Thursday, rebounding from Wednesday's slump. MIRA Pharmaceuticals ( MIRA ) shares surged 43% after the company said preclinical data showed the potential benefits of Ketamir-2, a treatment candidate for neurological and neuropsychiatric disorders. Viking Therapeutics ( VKTX ) shares increased 18% after the company reported...
Copyright 2023-2026 - www.financetom.com All Rights Reserved